Latest Movers & Shakers in ICU
AOP Health: Roland Bindeus becomes Senior Director Commercial
The Vienna-based pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health), which specializes in rare diseases and critical care medicine , is repositioning itself strategically. In order to offer patients and healthcare professionals state-of-the-art therapy concepts not only today
Read moreEssentia Health-Fargo Welcomes Critical Care Specialist Dr. Shu Xian (Suzanne) Lee
Essentia Health-Fargo is proud to welcome Dr. Shu Xian (Suzanne) Lee, who specializes in critical care. “I was drawn to practice at Essentia Health because of the camaraderie I witnessed amongst the staff, and I felt very welcomed to the community,” said Dr. Lee. “I do not have persona
Read moreXencor Appoints Barbara J. Klencke, M.D., to Board of Directors
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases announced the appointment of Barbara J. Klencke, M.D., to its board of directors. Dr. Klencke has more than 20 years of bio
Read moreJeanette Hedén Carlsson Resigns as Executive Vice President Brand & Communication at Getinge
Getinge announces that Jeanette Hedén Carlsson has decided to resign after 6 years as Executive Vice President, Brand & Communication, and member of the Executive Team. The process to recruit a successor will start immediately. ”Jeanette has successfully built and developed effecti
Read moreFresenius Appoints Robert Möller to the Management Board
Robert Möller appointed to the Fresenius Management Board; at the same time, Möller will assume responsibility for hospital group as CEO of Helios Health GmbH Dr. Francesco De Meo leaves the company Management Board team continues to drive froward transformation on the way to #
Read moreMarion Rottenberg is the New International Patient Advocacy Lead at AOP Health
The Vienna native has a wealth of experience in pharma and will be building up the European pioneer’s area of Patient Advocacy in the field of rare diseases and intensive care. As of June 2023, Marion Rottenberg has taken over the role of International Patient Advocacy Lead at AOP Heal
Read moreDr. George Goshua Appointed to Annals of Internal Medicine Editorial Board
George Goshua, MD, MSc, Assistant Professor of Medicine (Hematology) within the Classical Hematology Program at Smilow Cancer Hospital and Yale Cancer Center, has been invited to join the Annals of Internal Medicine Editorial Board for a 3-year term, effective July 1, 2023. Established
Read moreRamon W. Johnson, M.D., M.B.A, Becomes ABEM President
Ramon W. Johnson, M.D., M.B.A., is the new President of the American Board of Emergency Medicine (ABEM). Dr. Johnson has been an oral examiner since 1993 and has been a member of the Board of Directors since July 2015. He has served ABEM in a number of capacities, including as a Chief Examiner for
Read moreFresenius Medical Care appoints Martin Fischer as Chief Financial Officer
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases has appointed Martin Fischer (46) as Chief Financial Officer as of October 1, 2023. He will succeed Helen Giza who was appointed as Chief Executive Officer and Chair of the Management B
Read moreReplicate Bioscience Appoints Rachael Lester as Chief Business Officer
Biopharma executive with more than 20 years of global corporate, business development, and commercial strategy experience to join Replicate leadership team Replicate Bioscience, a company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology,
Read more